Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | ESR1 | P03372 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.42 |
| ▸ | DRD2 | P14416 | 12/20 | 0.42 |
| ▸ | DRD3 | P35462 | 9/20 | 0.42 |
| ▸ | DRD4 | P21917 | 7/20 | 0.42 |
| ▸ | HTR5A | P47898 | 1/20 | 0.42 |
| ▸ | DRD1 | P21728 | 5/20 | 0.40 |
| ▸ | DRD5 | P21918 | 5/20 | 0.40 |
| ▸ | HTR1D | P28221 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29706003 | 1.00 | MEN1 (0.42) | MEN1ESR1GAAKMT2AESR2 | |
| SCHEMBL6851155 | 0.92 | MEN1 (0.38) | MEN1ESR1GAAKMT2AESR2 | |
| SCHEMBL3222252 | 0.91 | ESR1 (0.55) | MEN1ESR1GAAKMT2AESR2 | |
| SCHEMBL15307384 | 0.91 | MEN1 (0.41) | MEN1ESR1GAAKMT2AESR2 | |
| SCHEMBL12476299 | 0.91 | MEN1 (0.41) | MEN1ESR1GAAKMT2AESR2 | |
| SCHEMBL9999646 | 0.89 | MEN1 (0.49) | MEN1ESR1GAAKMT2AESR2 | |
| SCHEMBL6812319 | 0.89 | ALDH1A1 (0.43) | MEN1ESR1GAAKMT2AESR2 | |
| SCHEMBL5372354 | 0.89 | CYP1A2 (0.43) | MEN1ESR1GAAKMT2AESR2 | |
| SCHEMBL29937164 | 0.89 | ALDH1A1 (0.46) | MEN1ESR1GAAKMT2AESR2 | |
| SCHEMBL1056365 | 0.89 | ALDH1A1 (0.46) | MEN1ESR1GAAKMT2AESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12049542-B2 | Polymers for use in electronic devices | DUPONT ELECTRONICS, INC. (US) | 2024-07-30 | — | — | US | disclosed |
| US-20230140877-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | LG CHEM, LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
| US-20230140877-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | LG CHEM, LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
| US-20230140749-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | LG CHEM, LTD. (KR) | 2023-05-04 | — | — | US | disclosed |
| US-20230140749-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | LG CHEM, LTD. (KR) | 2023-05-04 | — | — | US | disclosed |
| US-20210163683-A1 | POLYMERS FOR USE IN ELECTRONIC DEVICES | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2021-06-03 | — | — | US | disclosed |
| US-20210163683-A1 | POLYMERS FOR USE IN ELECTRONIC DEVICES | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2021-06-03 | — | — | US | disclosed |
| EP-2597932-B1 | MANUFACTURING METHOD FOR ORGANIC LIGHT-EMITTING DEVICE | SUMITOMO CHEMICAL CO (JP) | 2021-04-14 | — | — | EP | disclosed |
| CN-106588890-B | Antiviral compounds | 吉利德制药有限责任公司 | 2020-11-27 | — | — | CN | disclosed |
| EP-3626716-A1 | ANTIVIRAL COMPOUNDS | Gilead Pharmasset LLC (US) | 2020-03-25 | — | — | EP | disclosed |
| WO-2010132601-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2010-11-18 | — | — | WO | disclosed |
| US-20090045730-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2009-02-19 | — | — | US | disclosed |
| US-20090045730-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2009-02-19 | — | — | US | disclosed |
| US-20090045730-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2009-02-19 | — | — | US | disclosed |
| US-20090008606-A1 | NAPHTHALENE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-01-08 | — | — | US | disclosed |
| US-20090008605-A1 | NAPHTHALENE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-01-08 | — | — | US | disclosed |
| EP-0696287-B1 | UREIDO DERIVATIVES OF NAPHTHALENEPHOSPHONIC ACIDS AND PROCESS FOR THEIR PREPARATION | PHARMACIA & UPJOHN SPA (IT) | 2000-03-08 | — | — | EP | disclosed |
| US-5700788-A | Ureido derivatives of naphthalenephosphonic acids | PHARMACIA & UPJOHN S.P.A. (IT) | 1997-12-23 | — | — | US | disclosed |
| EP-0696287-A1 | UREIDO DERIVATIVES OF NAPHTHALENEPHOSPHONIC ACIDS AND PROCESS FOR THEIR PREPARATION | PHARMACIA & UPJOHN S.p.A. (IT) | 1996-02-14 | — | — | EP | disclosed |
| WO-1995023806-A2 | UREIDO DERIVATIVES OF NAPHTHALENEPHOSPHONIC ACIDS AND PROCESS FOR THEIR PREPARATION | PHARMACIA S.P.A. (IT) | 1995-09-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230140749-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | ARL1, LAS1L, AR | MEN1 1101/4885ESR1 23/4885GAA 3263/4885 |
| US-20090008606-A1 | NAPHTHALENE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | NAP1L4, NAP1L1, ARL1 | MEN1 689/4885ESR1 238/4885GAA 4145/4885 |
| US-20090008605-A1 | NAPHTHALENE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | NAP1L1, NAP1L4, NAT1 | MEN1 487/4885ESR1 241/4885GAA 4352/4885 |
| US-20090045730-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE | LEF1, RFT1, RIF1 | MEN1 1324/4885ESR1 164/4885GAA 4250/4885 |
| US-20230140877-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | CRY2, CRY1, GLI1 | MEN1 1050/4885ESR1 46/4885GAA 907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.